Jilin Province Huinan Changlong Bio-pharmacy Company Limited

HK$2.65As of Sun 8 Nov 2026, 12:00 UTC
HKEX:8049Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 14.20%
Div yield 10.30%
ROE 12.34%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.39
PE TTM 5.880
TSR TTM 38.06%
Mkt cap HK$1.485B
ROIC 20.06%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.36
26.78%
57.03%
Buy 10|0|3|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.03
5.01%
4.45%
18.57%
20.30%
Revenue¥M
62.81
61.09
60.57
61.98
0.93%
(5.40%)
(7.40%)
(2.47%)
Peers (US$189.4M)
Cap (US$)
PE
191.8M
12.31x
Capital
TTM
5Y
10Y
Leveragex
1.788
(4.439)
(3.435)
EBIT/Intx
0.833
0.111
0.098
Own earn%
122.48
235.97
237.03
Sh yield%
19.83
29.14
30.44
Owners
Insiders/Inst%
2.10
26.45
Short interest%
5.11
SBC / revenue%
3.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–4
$1 testx
0.0
Incr. ROIC%
6